tiprankstipranks
Aligos Therapeutics (ALGS)
NASDAQ:ALGS

Aligos Therapeutics (ALGS) Balance Sheet

77 Followers

Aligos Therapeutics Balance Sheet

Aligos Therapeutics's total assets for Q3 2023 were $85.85M, a decrease of -19.11% from the previous quarter. ALGS total liabilities were $31.03M for the fiscal quarter, a -14.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 146.69M$ 235.41M$ 265.30M$ 146.52M$ 107.73M
Total Liabilities
$ 42.79M$ 50.64M$ 45.26M$ 211.41M$ 121.48M
Total Equity Gross Minority
$ 103.92M$ 184.70M$ 220.04M$ -64.89M$ -13.75M
Total Capitalization
$ 113.33M$ 184.70M$ 220.04M$ -64.89M$ -13.75M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 13.01M$ 14.33M$ 13.86M
Currency in USD

Aligos Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis